OBM Transplantation is an international peer-reviewed Open Access journal, which covers all evidence-based scientific studies related to transplantation, including: transplantation procedures and the maintenance of transplanted tissues or organs; assimilation of grafted tissue and the reconstitution of removed organs or parts of organs; transplantation of heart, lung, kidney, liver, pancreatic islets and bone marrow, etc. Areas related to clinical and experimental transplantation are also of interest.

OBM Transplantation is committed to rapid review and publication, and we aim at serving the international transplant community with high accessibility as well as relevant and high quality content.

We welcome original clinical studies as well as basic science, reviews, short reports/rapid communications, case reports, opinions, technical notes, book reviews as well as letters to the editor. 


Archiving: full-text archived in CLOCKSS.

Rapid publication: manuscripts are undertaken in 8 days from acceptance to publication (median values for papers published in this journal in 2021, 1-2 days of FREE language polishing time is also included in this period).

Current Issue: 2023  Archive: 2022 2021 2020 2019 2018 2017

Special Issue

Liver Tumors and Liver Transplantation

Submission Deadline: February 25, 2019 (Open) Submit Now

Guest Editor

Chirag S. Desai, MD

Associate Professor of Surgery, Surgical Director, Liver Transplant Program, Director, Chronic Pancreatitis and Autologous Islet Cell Transplant Program, Department of Surgery, University of North Carolina, Chapel Hill, 4024 Burnett Womack Building, Chapel Hill, NC 27599, USA

Website | E-Mail

Research Interests: Liver transplantation; intestinal and multivisceral transplantation; liver and pancreatobiliary disorders; chronic pancreatitis; autologous islet cell transplantation

About This Topic

Indications for liver transplantation in adult and pediatric populations are increasing with improving outcomes. Due to increased awareness, improving diagnostic modalities and screening protocols hepatocellular carcinomas are identified early on in patients with chronic liver disease and increasing number of patients are listed and transplanted. Patients with hepatobalstoma, cholangiocarcioma and other malignancies in the setting of metabolic liver disease are more frequently transplanted then previously and the allocation system continues to evolve.
In this special issue on liver tumors and liver transplantation, submissions are invited related to this topic. Original research, quality and quantitative systematic analysis, review article, case reports pertaining to all liver tumors benign or malignant, in the adult or pediatric populations are welcome for submission. Topics involving allocation, waiting list management, pre-transplant down staging, tumor control therapies, surgical technique, molecular biology and pathology, outcomes and post-transplantation management are all eligible.

Planned Papers

Title: Liver transplantation for intrahepatic Cholangiocarcinoma
Authors: R. Mark Ghobrial, Keri Lunsford

Title: HCC and BCLC – a single center experience
Authors: Gerd Otto

Title: Liver Transplantation or Resection for Treatment of Hepatocellular Carcinoma in Patients with Well-Compensated Cirrhosis: a Decision Analysis Model
Authors: Amanda B. Cooper, M.D., Stephen M. Downs, M.D. Nicholas J. Skill PhD. JD., Kubal, Chandrashekhar Avinash MD. PhD and Mary A. Maluccio, M.D., MPH


Open Access Research Article

Incidence, Location, and Natural History of Perihepatic Fluid Collections after Orthotopic Liver Transplantation

Received: 18 February 2019;  Published: 18 November 2019;  doi: 10.21926/obm.transplant.1904092


Objective: The purpose of this study was to evaluate the common locations of perihepatic fluid collections after liver transplantation, assess their complexity, and understand their natural history and clinical significance. Materials and Methods: A retrospective analysis of 189 postoperative orthotopic liver transplant patients was performed [...]
Open Access Original Research

Liver Transplantation or Resection for Treatment of Hepatocellular Carcinoma in Patients with Well-Compensated Cirrhosis: A Decision Analysis Model

Received: 18 March 2019;  Published: 13 May 2019;  doi: 10.21926/obm.transplant.1902063


Hepatocellular carcinoma (HCC) is a lethal tumor, for which liver resection and transplantation are the only potentially curative treatments. No prospective, randomized study has compared survival in patients with compensated cirrhosis after the two operations. Decision analysis modeling is an objective method to quantify risks and benefits [...]